A+ Academy Cloud Feast, big coffee hand in hand to talk about the frontiers of lymphoma treatment

With the aging of the population and the continuous improvement of the level of medical diagnosis, the incidence of lymphoma in China is also showing an upward trend, and lymphoma is gradually becoming one of
the important malignant tumors affecting human health.

【A+ College】Advances in DLBCL treatment

DLBCL is the most common subtype of non-Hodgkin lymphoma (NHL).

【A+ College】Advances in MCL treatment

MCL is a more aggressive subtype of NHL with a poor prognosis
.

【A+ College】CLL treatment progress

CLL is a mature B lymphocyte clonal proliferative tumor
.

【A+ Academy】Application of Minimal Residual Disease (MRD) in CLL

Limited-cycle combination therapy and MRD-guided CLL treatment mode are the hot spots
in the field of CLL therapy.
MRD in this treatment model is an important indicator
of treatment decision and efficacy evaluation.
So what does MRD mean in the CLL, what are the detection methods, and the corresponding clinical studies? 【A+ College】Professor Cui Guohui of Union Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology was invited to give a lecture
.

【A+ College】CLL treatment options are single or combined

With the application and development of new targeted drugs in CLL therapy, CLL has gradually formed a treatment model for chronic disease management, and the application of these drugs has improved the survival
of CLL patients.
At present, domestic and foreign guidelines recommend BTK inhibitor single-drug treatment, while targeted drugs combined with immunochemotherapy, targeted drugs and other treatment modes are also actively exploring and clinical application, in the CLL therapy, how should single-drug or combination regimens be chosen? 【A+ College】Professor Tang Xiaoqiong of the First Affiliated Hospital of Chongqing Medical University was invited to give a lecture
.

This material is supported by AstraZeneca and is for the information of healthcare professionals only and is not intended for promotional purposes

CN-101187，CN-101185，CN-101172，CN-101174，CN-101169 ，CN-101178